Chemoprevention of breast cancer among Asian women-its perspective and problems

Hironobu Sasano, Takashi Suzuki

Research output: Contribution to journalShort surveypeer-review

3 Citations (Scopus)


Chemoprevention of breast cancer employing tamoxifen and others has been demonstrated to be effective in reducing the frequency of developing breast malignancy in Western countries. In Asian countries, the frequency of breast cancer as well as its premalignant lesions has recently increased. Therefore, the possible chemoprevention may benefit those women with potential high risks of developing breast cancer and with premalignant lesions. However, the details of these findings of chemoprevention in Western countries have not been available for women with Asian descendant. In addition, risk factors of developing breast cancer in healthy women have not been established in Asian countries compared to Western countries with relative paucity of familial breast cancer cases. Thus, possible chemoprevention of breast cancer in Asian countries may be targeted toward those with established premalignant breast lesions such as ductal carcinoma in situ and/or atypical ductal hyperplasia. However, due to their recent increment of their incidence, biological and/or clinical features of these premalignant breast lesions have not been extensively characterized in Asian women and further investigations are required for wide spread chemoprevention.

Original languageEnglish
Pages (from-to)266-268
Number of pages3
JournalBiomedicine and Pharmacotherapy
Issue number6
Publication statusPublished - 2006 Jul


  • Breast cancer
  • Chemoprevention
  • Estrogen
  • Premalignant lesions


Dive into the research topics of 'Chemoprevention of breast cancer among Asian women-its perspective and problems'. Together they form a unique fingerprint.

Cite this